Atlas FDA

FLOSEAL Hemostatic Matrix/ Floseal Special Applicator Tips

FDA premarket approval P990009/S050 · decided 2017-11-01

Approval details

PMA number
P990009
Supplement
S050
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
FLOSEAL Hemostatic Matrix/ Floseal Special Applicator Tips
Generic name
Absorbable collagen hemostatic agent with thrombin
Applicant
Baxter Healthcare Corp
Date received
2017-10-02
Decision date
2017-11-01
Days to decision
30 days
Decision code
OK30
Product code
PMX
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Round Lake, IL
Statement
Change of the Bacterial Endotoxin Test (BET) method to Limulus Amebocyte Lysate (LAL) Kinetic Turbidimetric Method.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
PrisMax System Version 2 (K190910)Baxter Healthcare Corp2019-07-25
PrisMax Control Unit (K163530)Baxter Healthcare Corp2017-05-03
ULTRAFUSE (K130531)Baxter Healthcare Corp2014-04-08
NEUTRAL LUER ACTIVATED DEVICE (ONE-LINK NEEDLE-FREE IV CONNECTOR) AND EXTENSION SETS (K132734)Baxter Healthcare Corp2013-10-08
LARGE BORE STOPCOCK WITH ROTATING MALE LUER LOCK/LARGE BORE STOPCOCK WITH EXTENSION SET, GANG LARGE BORE STOPCOCK MANIFO (K130245)Baxter Healthcare Corp2013-03-01
INTERLINK SYSTEM BURETROL SOLUTION SETS, INTERLINK SYSTEM BURETROL SOLUTION SETS, CONTINUED, CLEARLINK SYSTEM BURETROL S (K123874)Baxter Healthcare Corp2013-01-10
INTERLINK SYSTEM LEVER LOCK CANNULA WITH CHECK VALVE, SECONDARY MEDICATION SETS, SOLUTION SETS, CONTINU-FLO SOLUTION SET (K123868)Baxter Healthcare Corp2013-01-08
FLOWEASE [SUBCUTANEOUS] INFUSION SET (K121092)Baxter Healthcare Corp2012-06-29